Back to Results
First PageMeta Content
Headaches / Sinusitis / Otolaryngology / Sinus / Drug-eluting stent / Medicine / Rhinology / General practice


Intersect ENT Appoints Chas McKhann as Chief Commercial Officer Menlo Park, Calif. – February 2, 2015––Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear,
Add to Reading List

Document Date: 2015-02-03 12:17:27

Open Document

File Size: 27,15 KB

Share Result on Facebook

Company

Johnson & Johnson / Boston Scientific / Intersect ENT Inc. / McKinsey & Company / Cordis / /

Country

United States / /

Event

Employment Change / /

Facility

Stanford University / /

IndustryTerm

healthcare landscape / medical technologies / experience commercializing products / /

MedicalCondition

chronic infections / sleep apnea / chronic sinusitis / inflammatory condition leading / /

MedicalTreatment

sinus surgery / /

Organization

Stanford University / /

Person

Revascularization / Menlo Park / Lisa Earnhardt / Chas McKhann / /

Position

CEO / president and chief executive officer / director in the strategy consulting practice / Chief Commercial Officer / director of Marketing / consultant / worldwide vice president of Marketing / vice president of Marketing and general manager / /

ProvinceOrState

California / /

SportsLeague

Stanford University / /

URL

www.intersectENT.com / /

SocialTag